/b/veterinary-news/posts/25226 Boehringer Ingelheim Vetmedica has launched Prascend, the first licensed product for the treatment of Pituitary Pars Intermedia Dysfunction (PPID) in horses, commonly known as Equine Cushing's Disease. Prascend contains pergolide mesylate, anden-USTelligent Community 10